retatrutide glp 3 GLP-3 10mg Vial (Retatrutide) | Research Peptide GLP-3 30mg Vial (Retatrutide) |

If you have never used a peptide pen before, the device can feel unfamiliar for the first few uses

Woodcock is director of the FDAs Center for Drug Evaluation and Research.

Profound Weight Loss: Up to 22.5% body weight reduction in obese individuals over 72 weeks 2

Dysesthesia (retatrutide-specific)

GLP-1 users showed a 49% higher risk for vitamin D deficiency compared to people on SGLT2 inhibitors and a 32% higher risk compared to those on DPP-4 inhibitors

Open communication with your healthcare team ensures that constipation and other adverse effects are managed appropriately while maintaining the benefits of weight loss therapy